Charmacy Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
77.00
74.00
141.00
39.00
61.00
62.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-22.00
-242.00
-63.00
-143.00
23.00
-108.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
113.00
-102.00
55.00
-20.00
150.00
7.00
Cash Flow from Investing Activities
-16.00
43.00
83.00
-29.00
-61.00
-83.00
Cash Flow from Financing Activities
-32.00
107.00
-226.00
86.00
-5.00
58.00
Net Cash Inflow / Outflow
63.00
48.00
-87.00
36.00
82.00
-17.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Charmacy Pharmaceutical Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
77.1883373235659
37.6843680939262
40.00
104.83%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-22.8183489828881
7.96579257088
-29.00
-386.45%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
113.543131932818
110.79791868937
3.00
2.48%
Cash Flow from Investing Activities
-16.9625521042809
-132.822841826004
116.00
87.23%
Cash Flow from Financing Activities
-32.7671361875062
52.4710128580016
-84.00
-162.45%
Net Cash Inflow / Outflow
63.8229424176923
32.1537422733112
31.00
98.49%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.0094987766617969
1.70765255194447
-1.00
-99.44%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 211.09% vs -284.01% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
113.54
-102.21
211.09%






